1-800-729-1232

hearing impairment

Understanding and Managing Adverse Events in Patients Treated with Tepezza

Product Liability / November 21, 2023 / 4 minutes of reading / By / , , , , , , , , , ,

Tepezza (teprotumumab) has emerged as a groundbreaking treatment for thyroid eye disease, offering hope to patients with this rare condition. Approved by the FDA in January 2020, Tepezza has shown remarkable efficacy in reducing eye bulging and double vision. However, like any medication, it is important to be aware of the potential adverse events associated […]

Understanding and Managing Adverse Events in Patients Treated with Tepezza Read More »

Tepezza: FDA Adds Hearing Loss and Impairment Warnings to Drug Label

Product Liability / November 21, 2023 / 4 minutes of reading / By / , , , , , , , , ,

The U.S. Food and Drug Administration (FDA) recently took a significant step toward enhancing patient safety by updating the warning label for Horizon Pharmaceutical’s drug, Tepezza. Tepezza is a medication used to treat thyroid eye disease (TED), a chronic condition associated with eye inflammation and related vision problems. This Tepezza warning label update includes important

Tepezza: FDA Adds Hearing Loss and Impairment Warnings to Drug Label Read More »

Tepezza

Product Liability / April 11, 2024 / 11 minutes of reading / By / , , , , , , , , , , , , , ,

Did You Have Hearing Problems After Tepezza® Injections? A study shows 16% of patients taking Horizon Therapeutics’ thyroid eye disease drug Tepezza may experience long-term otologic symptoms like hearing loss and/or tinnitus, which can persist even after the drug treatment is discontinued. Start My Tepezza Hearing Loss Lawsuit Claim Now Please enable JavaScript in your

Tepezza Read More »

Scroll to Top